… been regularly assessed in clinical or research settings; a … of 678 randomized clinical trials
for psoriasis.22 Furthermore, … to‐severe plaque psoriasis in the clinical practice setting, and to …

… PGA is increasingly being used to define treatment efficacy in clinical trials and has been …
of psoriasis severity in the clinical setting. Several versions of the PGA exist, and, in clinical …

… Secondary forms of pustular psoriasis, in the setting of plaque psoriasis, may be transient
or become the new morphology after conversion. This may be seen as well in erythrodermic …

… plaque psoriasis were included in this analysis (Figure 1). Missing data did not exceed 2.8%
for any of the variables analyzed. Mean (SD) age of the patients was 48.6 (15.5) years; they …

… clinical … plaque psoriasis, the objective of the present investigation was to determine how
dermatologists in the real-world clinical setting define and treat moderate plaque psoriasis…

… treatment targets toward which clinicians and patients with psoriasis can strive to inform …
patients with psoriasis in clinical settings. With the defined treatment targets, both clinicians and …

… Based on our results, secukinumab demonstrates a high effectiveness in the treatment of
plaque PsO in daily clinical practice. Thus, PASI 75 and PASI 90 response rates achieved at …

… in response to therapies used in the clinical setting. … psoriasis provides additional evidence
to suggest that the performance of therapies for psoriasis in the real-world clinical setting is …

… onset or the clinical course of psoriasis. Chronic plaque psoriasis occurs in a variety of
clinical forms primarily distinguished by size, distribution, and dynamics of psoriatic plaques. In …

… % achieved clinically significant clearance of psoriasis with a … in RCTs compared to the
clinical setting. However, despite … of clinical care of patients and not for the purposes of clinical …